Intra-individual comparison of human nasal chondrocytes and debrided knee chondrocytes: Relevance for engineering autologous cartilage grafts.


Journal

Clinical hemorheology and microcirculation
ISSN: 1875-8622
Titre abrégé: Clin Hemorheol Microcirc
Pays: Netherlands
ID NLM: 9709206

Informations de publication

Date de publication:
2020
Historique:
pubmed: 21 11 2019
medline: 3 6 2020
entrez: 21 11 2019
Statut: ppublish

Résumé

Implantation of autologous chondrocytes for cartilage repair requires harvesting of undamaged cartilage, implying an additional joint arthroscopy surgery and further damage to the articular surface. As alternative possible cell sources, in this study we assessed the proliferation and chondrogenic capacity of debrided Knee Chondrocytes (dKC) and Nasal Chondrocytes (NC) collected from the same patients. Matched NC and dKC pairs from 13 patients enrolled in two clinical studies (NCT01605201 and NCT026739059) were expanded in monolayer and then chondro-differentiated in 3D collagenous scaffolds in medium with or without Transforming Growth Factor beta 1 (TGFβ1). Cell proliferation and amount of cartilage matrix production by these two cell types were assessed. dKC exhibited an inferior proliferation rate than NC, and a lower capacity to chondro-differentiate. Resulting dKC-grafts contained lower amounts of cartilage specific matrix components glycosaminoglycans and type II collagen. The cartilage forming capacity of dKC did not significantly correlate with specific clinical parameters and was only partially improved by medium supplemention with TGFβ1. dKC exhibit a reproducibly poor capacity to engineer cartilage grafts. Our in vitro data suggest that NC would be a better suitable cell source for the generation of autologous cartilage grafts.

Identifiants

pubmed: 31743993
pii: CH199236
doi: 10.3233/CH-199236
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

67-78

Auteurs

Gyözö Lehoczky (G)

Department of Surgery, University Hospital of Basel, Basel, Switzerland.
Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.

Francine Wolf (F)

Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.

Marcus Mumme (M)

Department of Surgery, University Hospital of Basel, Basel, Switzerland.
Department of Orthopaedics, University Children's Hospital Basel, Basel, Switzerland.

Sebastian Gehmert (S)

Department of Orthopaedics, University Children's Hospital Basel, Basel, Switzerland.

Sylvie Miot (S)

Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.

Martin Haug (M)

Department of Surgery, University Hospital of Basel, Basel, Switzerland.

Marcel Jakob (M)

Department of Surgery, University Hospital of Basel, Basel, Switzerland.

Ivan Martin (I)

Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.

Andrea Barbero (A)

Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH